Switch theme
Sign up to access all valuation multiples
Voxel SA is a network of diagnostic imaging laboratories created for patients and to increase access to high-quality tests. The company operates diagnostic imaging centers and laboratories and provides several services such as magnetic resonance imaging, computed tomography and positron emission tomography. It has 33 specialised laboratories in 21 cities throughout Poland.
2005
396
LTM Revenue $141M
LTM EBITDA $49.0M
$475M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Voxel has a last 12-month revenue (LTM) of $141M and a last 12-month EBITDA of $49.0M.
In the most recent fiscal year, Voxel achieved revenue of $112M and an EBITDA of $40.2M.
Voxel expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Voxel valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $141M | XXX | $112M | XXX | XXX | XXX |
| Gross Profit | $141M | XXX | $37.2M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $49.0M | XXX | $40.2M | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 36% | XXX | XXX | XXX |
| EBIT | $35.7M | XXX | $31.2M | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 28% | XXX | XXX | XXX |
| Net Profit | $26.9M | XXX | $19.7M | XXX | XXX | XXX |
| Net Margin | 19% | XXX | 17% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Voxel's stock price is PLN 159 (or $42).
Voxel has current market cap of PLN 1.7B (or $443M), and EV of PLN 1.8B (or $475M).
See Voxel trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $475M | $443M | XXX | XXX | XXX | XXX | $2.59 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Voxel has market cap of $443M and EV of $475M.
Voxel's trades at 4.2x EV/Revenue multiple, and 11.8x EV/EBITDA.
Equity research analysts estimate Voxel's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Voxel has a P/E ratio of 16.5x.
See valuation multiples for Voxel and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $443M | XXX | $443M | XXX | XXX | XXX |
| EV (current) | $475M | XXX | $475M | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | 4.2x | XXX | XXX | XXX |
| EV/EBITDA | 9.7x | XXX | 11.8x | XXX | XXX | XXX |
| EV/EBIT | 13.3x | XXX | 15.2x | XXX | XXX | XXX |
| EV/Gross Profit | 3.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 16.5x | XXX | 22.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 21.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVoxel's last 12 month revenue growth is 10%
Voxel's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $15K for the same period.
Voxel's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Voxel's rule of X is 60% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Voxel and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 36% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 36% | XXX | XXX | XXX |
| Rule of 40 | 36% | XXX | 46% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 60% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $15K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Voxel acquired XXX companies to date.
Last acquisition by Voxel was XXXXXXXX, XXXXX XXXXX XXXXXX . Voxel acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Voxel founded? | Voxel was founded in 2005. |
| Where is Voxel headquartered? | Voxel is headquartered in Poland. |
| How many employees does Voxel have? | As of today, Voxel has 396 employees. |
| Is Voxel publicy listed? | Yes, Voxel is a public company listed on WAR. |
| What is the stock symbol of Voxel? | Voxel trades under VOX ticker. |
| When did Voxel go public? | Voxel went public in 2011. |
| Who are competitors of Voxel? | Similar companies to Voxel include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Voxel? | Voxel's current market cap is $443M |
| What is the current revenue of Voxel? | Voxel's last 12 months revenue is $141M. |
| What is the current revenue growth of Voxel? | Voxel revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Voxel? | Current revenue multiple of Voxel is 3.4x. |
| Is Voxel profitable? | Yes, Voxel is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Voxel? | Voxel's last 12 months EBITDA is $49.0M. |
| What is Voxel's EBITDA margin? | Voxel's last 12 months EBITDA margin is 35%. |
| What is the current EV/EBITDA multiple of Voxel? | Current EBITDA multiple of Voxel is 9.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
